DK2598122T3 - Sammensætning omfattende shellak og/eller et salt deraf og natriumstivelseglycolat - Google Patents

Sammensætning omfattende shellak og/eller et salt deraf og natriumstivelseglycolat Download PDF

Info

Publication number: DK2598122T3
Authority: DK; Denmark
Prior art keywords: shellak; salt; composition including; sodium starch; starch glycolate
Prior art date: 2010-07-26

Application number

DK11738822.3T

Other languages

English (en)

Inventor

Daniele Giovannone

Angelis Carlo De

Original Assignee

Gnosis Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-07-26

Filing date

2011-06-30

Publication date

2015-10-19

2011-06-30 Application filed by Gnosis Spa filed Critical Gnosis Spa

2015-10-19 Application granted granted Critical

2015-10-19 Publication of DK2598122T3 publication Critical patent/DK2598122T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Cosmetics (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

DK11738822.3T 2010-07-26 2011-06-30 Sammensætning omfattende shellak og/eller et salt deraf og natriumstivelseglycolat DK2598122T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US36772010P	2010-07-26	2010-07-26
ITMI2010A001386A IT1401146B1 (it)	2010-07-27	2010-07-27	Composizione comprendente shellac e/o un suo sale e sodio amido glicolato
PCT/IB2011/052896 WO2012014104A2 (en)	2010-07-26	2011-06-30	Composition comprising shellac and/or a salt thereof and sodium starch glycolate

Publications (1)

Publication Number	Publication Date
DK2598122T3 true DK2598122T3 (da)	2015-10-19

Family

ID=43598463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK11738822.3T DK2598122T3 (da)	2010-07-26	2011-06-30	Sammensætning omfattende shellak og/eller et salt deraf og natriumstivelseglycolat

Country Status (23)

Country	Link
US (1)	US9750815B2 (da)
EP (1)	EP2598122B1 (da)
JP (1)	JP5873868B2 (da)
KR (1)	KR101931638B1 (da)
CN (1)	CN103052381B (da)
AU (1)	AU2011284387B2 (da)
BR (1)	BR112013001962B1 (da)
CA (1)	CA2804715C (da)
DK (1)	DK2598122T3 (da)
EA (1)	EA025644B1 (da)
ES (1)	ES2553604T3 (da)
GE (1)	GEP20156363B (da)
HR (1)	HRP20151125T1 (da)
HU (1)	HUE026267T2 (da)
IT (1)	IT1401146B1 (da)
MX (1)	MX336929B (da)
NZ (1)	NZ606248A (da)
PL (1)	PL2598122T3 (da)
PT (1)	PT2598122E (da)
RS (1)	RS54305B1 (da)
SG (1)	SG186928A1 (da)
SI (1)	SI2598122T1 (da)
WO (1)	WO2012014104A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20131906A1 (it) *	2013-11-18	2015-05-19	Gnosis Spa	Composizioni solide orali a lento rilascio
US10553327B2 (en) *	2014-05-26	2020-02-04	Furukawa Electric Co., Ltd.	Aluminum alloy conductor wire, aluminum alloy stranded wire, coated wire, wire harness and method of manufacturing aluminum alloy conductor wire

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8603957D0 (en) *	1986-02-18	1986-03-26	Ciba Geigy Ag	Acylated quinone derivatives
CN1260172A (zh) *	1998-12-18	2000-07-19	国家医药管理局上海医药工业研究院	右旋酮洛芬制剂
PT1207860E (pt) *	1999-09-02	2008-01-24	Nostrum Pharmaceuticals Inc	Formulação de peletes de libertação controlada
AUPQ672800A0 (en) *	2000-04-06	2000-05-04	Natraherbal Pty Ltd	Garlic supplement for deodoriser
IT1318597B1 (it)	2000-06-23	2003-08-27	A C R Applied Coating Res S A	Uso di un amido ad alto contenuto di amilosio acetilato epregelatinizzato.
KR20040044992A (ko)	2001-09-28	2004-05-31	썬 파마슈티컬 인더스트리스 리미티드	당뇨병 치료용 투여형태
US20040103821A1 (en) *	2002-11-29	2004-06-03	Freund Industrial Co., Ltd.	Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and glazed oil-based confectionary using same
US20050031775A1 (en)	2003-08-07	2005-02-10	Charles Signorino	High gloss film coating and stable solution therefor
GB0320020D0 (en) *	2003-08-27	2003-10-01	Mw Encap Ltd	Improved formulation for providing an enteric coating material
CA2705518A1 (en) *	2007-11-13	2009-05-22	Hercules Incorporated	Water dispersible enteric coating formulation for nutraceutical and pharmaceutical dosage forms
DE102008063800A1 (de) *	2008-12-19	2010-06-24	Henkel Ag & Co. Kgaa	Beschichtete Färbemittel
WO2010075290A1 (en)	2008-12-22	2010-07-01	President And Fellows Of Harvard College	Unsaturated heterocyclic inhibitors of necroptosis
JP2012513481A (ja)	2008-12-23	2012-06-14	プレジデントアンドフェロウズオブハーバードカレッジ	ネクロトーシスの小分子阻害剤
JP2012514649A (ja)	2009-01-09	2012-06-28	セネレックスバイオファーマ，インコーポレーテッド	経口持続放出抗うつ薬製剤
WO2010132072A1 (en)	2009-05-15	2010-11-18	Neuraxon, Inc	Treatment or prevention of migraine by dosing at aura
US8629149B2 (en)	2009-09-04	2014-01-14	Zalicus Pharmaceuticals Ltd.	Oxopiperazine derivatives for the treatment of pain and epilepsy

2010
- 2010-07-27 IT ITMI2010A001386A patent/IT1401146B1/it active
2011
- 2011-06-30 WO PCT/IB2011/052896 patent/WO2012014104A2/en active Application Filing
- 2011-06-30 MX MX2013001061A patent/MX336929B/es active IP Right Grant
- 2011-06-30 GE GEAP201113011A patent/GEP20156363B/en unknown
- 2011-06-30 RS RS20150685A patent/RS54305B1/en unknown
- 2011-06-30 EP EP11738822.3A patent/EP2598122B1/en active Active
- 2011-06-30 PT PT117388223T patent/PT2598122E/pt unknown
- 2011-06-30 JP JP2013521251A patent/JP5873868B2/ja active Active
- 2011-06-30 SG SG2013000658A patent/SG186928A1/en unknown
- 2011-06-30 BR BR112013001962-0A patent/BR112013001962B1/pt active IP Right Grant
- 2011-06-30 ES ES11738822.3T patent/ES2553604T3/es active Active
- 2011-06-30 PL PL11738822T patent/PL2598122T3/pl unknown
- 2011-06-30 EA EA201370024A patent/EA025644B1/ru not_active IP Right Cessation
- 2011-06-30 NZ NZ606248A patent/NZ606248A/en unknown
- 2011-06-30 US US13/812,465 patent/US9750815B2/en active Active
- 2011-06-30 SI SI201130653T patent/SI2598122T1/sl unknown
- 2011-06-30 HU HUE11738822A patent/HUE026267T2/en unknown
- 2011-06-30 KR KR1020137001826A patent/KR101931638B1/ko active IP Right Grant
- 2011-06-30 DK DK11738822.3T patent/DK2598122T3/da active
- 2011-06-30 AU AU2011284387A patent/AU2011284387B2/en active Active
- 2011-06-30 CA CA2804715A patent/CA2804715C/en active Active
- 2011-06-30 CN CN201180034989.2A patent/CN103052381B/zh active Active
2015
- 2015-10-23 HR HRP20151125TT patent/HRP20151125T1/hr unknown

Also Published As

Publication number	Publication date
PT2598122E (pt)	2015-12-07
SI2598122T1 (sl)	2015-12-31
HUE026267T2 (en)	2016-06-28
EA025644B1 (ru)	2017-01-30
WO2012014104A3 (en)	2012-06-07
EA201370024A1 (ru)	2013-06-28
AU2011284387A2 (en)	2013-03-07
RS54305B1 (en)	2016-02-29
CA2804715A1 (en)	2012-02-02
US9750815B2 (en)	2017-09-05
NZ606248A (en)	2015-02-27
CA2804715C (en)	2017-12-19
MX336929B (es)	2016-02-05
IT1401146B1 (it)	2013-07-12
ES2553604T3 (es)	2015-12-10
WO2012014104A2 (en)	2012-02-02
BR112013001962A2 (pt)	2016-05-24
CN103052381A (zh)	2013-04-17
ITMI20101386A1 (it)	2012-01-28
SG186928A1 (en)	2013-02-28
JP5873868B2 (ja)	2016-03-01
US20130133551A1 (en)	2013-05-30
KR20130041133A (ko)	2013-04-24
EP2598122A2 (en)	2013-06-05
CN103052381B (zh)	2015-04-01
KR101931638B1 (ko)	2018-12-24
AU2011284387A1 (en)	2013-02-07
AU2011284387B2 (en)	2016-08-04
MX2013001061A (es)	2013-03-20
BR112013001962B1 (pt)	2021-07-06
HRP20151125T1 (hr)	2015-11-20
EP2598122B1 (en)	2015-09-16
PL2598122T3 (pl)	2016-02-29
JP2013532679A (ja)	2013-08-19
GEP20156363B (en)	2015-09-10

Publication	Publication Date	Title
NO2020001I1 (no)	2020-01-16	Gilteritinib eller et salt derav
NO2021013I1 (no)	2021-03-23	filgotinib or a salt thereof
NO2017026I2 (no)	2017-06-12	Alektinib eller salt eller solvat derav
NO2017057I1 (no)	2017-11-10	pibrentasvir eller et farmasøytisk akseptabelt salt derav
NO2019019I1 (no)	2019-04-24	Doravirin eller et farmasøytisk akseptabelt salt derav
NO2017024I1 (no)	2017-05-30	Elosulfase alfa eller et farmasøytisk akseptabelt salt derav
SMT201600072B (it)	2016-04-29	Sale sodico di 6-fluoro-3-idrossi-2-pirazina carbossammide
BR112013002170A2 (pt)	2019-09-24	manequim articulado
DK3590949T3 (da)	2022-07-11	Ribonukleinsyrer indeholdende n1-methyl-pseudouracil og anvendelse heraf
DK3033945T3 (da)	2019-09-23	Slagteanlæg
DK2545598T3 (da)	2014-05-05	Bøjningstransducer
DK3378856T3 (da)	2020-12-21	Krystallinske methylthioniniumchlorid-hydrater
NO20092615A1 (no)	2011-01-10	Datamaskinimplementert tidlig dropping
BR112012028007A2 (pt)	2016-08-09	composição aquosa
BR112013006258A2 (pt)	2019-09-24	manequim articulado
IT1398461B1 (it)	2013-02-22	Manichino snodato
DK2598122T3 (da)	2015-10-19	Sammensætning omfattende shellak og/eller et salt deraf og natriumstivelseglycolat
DK2561504T5 (da)	2014-07-21	Belyst facade
ES1073714Y (es)	2011-05-03	Jamonero
ES1069571Y (es)	2009-07-20	Jamonero
DK2532744T3 (da)	2017-11-13	Glycerin-3-phosphatacyltransferasehomolog og anvendelse deraf
ES1072240Y (es)	2010-09-09	Jamonero
ES1073503Y (es)	2011-03-17	Jamonero multiposicion
FI8681U1 (fi)	2010-04-12	Tarttuja
ZA201300132B (en)	2013-08-28	Composition comprising shellac and/or a salt thereof and sodium starch glycolate